Asia-Pacific Epigenetics Market has been estimated at USD 106.69 million in 2016 and is projected to reach USD 224.09 million by 2021, at a CAGR of 16% during the forecast period from 2016 to 2021.
As humans grows and develops, depending on the interactions they made, circumstances they live in some genes become dormant or active to make who they are. Epigenetics is the study of these changes and factors that influence them. These changes decide how a cell should act and it may cause diseases like cancer sometimes. These epigenomes are sometimes inherited by their offspring.
Browse market data tables and in-depth TOC of the Asia-Pacific Epigenetics Market to 2021 @ http://www.marketdataforecast.com/market-reports/asia-pacific-epigenetics-market-1972/
Some of the factors like rising prevalence of cancer, increasing funding in R&D, and increasing frequency of research activities are driving the growth of the market. However, lack of trained professionals and high cost of instruments are some of the factors restraining the market.
Asia-Pacific Epigenetics Market is segmented based on Product and Research Area. Based on Product, market is segmented into Enzymes, Instruments & Consumables, KITS, and Reagents. Based on Research Area, market is segmented into Developmental Biology, Oncology, Drug Delivery. Based on Enzymes, market is further segmented into DNA-Modifying Enzymes, Protein-Modifying Enzymes, RNA-Modifying Enzymes. Further based on Instruments & Consumables, market is segmented into Mass Spectrometers, Next-Generation Sequencers, QPCR, Sonicators, and others. Based on KITS, market is further segmented into Bisulfite Conversion KITS, Chip-Sequence KITS, RNA Sequencing KITS, Whole-Genome Amplification KITS, 5-HMC and 5-MC Analysis KITS, others. Based on Reagents, market is further segmented into Antibodies, buffers, Histones, Magnetic Beads, Primers and others. Oncology segment holds the highest share in the market but drug discovery segment is expected to grow at highest CAGR during Forecast Period.
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/asia-pacific-epigenetics-market-1972/request-sample
Geographically, market is further segmented into India, China, Japan, Australia and South Korea. Asia-Pacific market is expected to grow at highest CAGR during the forecast period owing to the developing countries like India and China, and increasing R&D spending by companies.
Major players in the Asia-Pacific epigenetics market are Abcam plc., Illumina, Inc., QIAGEN N.V., Merck & Co., New England Biolabs, Inc., Sigma-Aldrich Corporation, Thermo Fisher Scientific, Inc., Active Motif, Diagenode, Inc. and Zymo Research Corporation.
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases